On February 22, Wu Zhen,Deputy Director of State Food and Drug Administration visited YRPG, accompanied byZhu Bulou,Vice Secretary General of Jiangsu Government, Hu Xiaoshu, Director of Jiangsu Food and Drug Administration, Ye Yaoxuand Yao Xinzhong,Vice Directors , He Rong,Secretary of Taizhou Party Standing Committee, Cao Yumei,Vice Mayor, Chen Guanhua,Taizhou Food and Drug Administration, Xu Jingren,Chairman of Board of Directors of YRPG and Xu Haoyu,Vice Chairman of YRPG.
Wu Zhen and others visited the stereoscopic warehouse, No.2 Oral Liquid Solution Workshop, Freeze-dried Powder Injection Workshop and the central laboratory. Abiding by laws and regulations, YRPG comprehensively promoted quality control.No.2Solid PreparationWorkshop passed EU certificate in October 2010. In the sample inspection of basic medicines, YRPG products with 250 specifications and batches were qualified. Wu Zhen gave the praise that it was the focus on quality that won public praise for YRPG products.
Chairman Xu Jingren mainly reported R&D innovation and quality of YRPG. In recent years, YRPG has carried out R&D innovation strategy by guiding enterprise development by innovation. The R&D strategy is transformed from "predomination of imitation" to "predomination of innovation and combination of imitation and creation". Sales of last year were over 25 billion yuan. In January this year, YRPG was in a momentum of rapid growth. The sales and profit taxation respectively increased by 69% and 30% on a year-on-year basis, making a good start.
Wu Zhen showed admiration for the rapid development of YRPG in recent years. He said that the rapid development of YRPG was not separated from its focus on R&D innovation and quality. He said that a strong pharmaceutical enterprise and its R&D capacity determined the level of drug supervision. YRPG should give full play to its products and technological advantages. On the basis of maintaining the existing products, YRPG should exert efforts to develop new products. YRPG should seize the market opportunity and maintain rapid development in the fierce competition, making greater contributions to the pharmaceutical cause.
The symposium went on in a relaxed atmosphere. Leaders from State Drug and Food Administration Zhang Wei, Sun Xianze and Li Guoqing talked senior managers in the research institute. With the concern, instruction and inspiration of those leaders, the researchers would work harder to make new achievements in scientific research.